SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH

Many studies estimate that chromosomal mosaicism within the cleavage-stage human embryo is high. However, comparison of two unique methods of aneuploidy screening of blastomeres within the same embryo has not been conducted and may indicate whether mosaicism has been overestimated due to technical inconsistency rather than the biological phenomena. The present study investigates the prevalence of chromosomal abnormality and mosaicism found with two different single cell aneuploidy screening techniques. Thirteen arrested cleavage-stage embryos were studied. Each was biopsied into individual cells (n = 160). The cells from each embryo were randomized into two groups. Those destined for FISH-based aneuploidy screening (n = 75) were fixed, one cell per slide. Cells for SNP microarray-based aneuploidy screening (n = 85) were put into individual tubes. Microarray was significantly more reliable (96%) than FISH (83%) for providing an interpretable result (P = 0.004). Markedly different results were obtained when comparing microarray and FISH results from individual embryos. Mosaicism was significantly less commonly observed by microarray (31%) than by FISH (100%) (P = 0.0005). Although FISH evaluated fewer chromosomes per cell and fewer cells per embryo, FISH still displayed significantly more unique genetic diagnoses per embryo (3.2 ± 0.2) than microarray (1.3 ± 0.2) (P < 0.0001). This is the first prospective, randomized, blinded and paired comparison between microarray and FISH-based aneuploidy screening. SNP microarray-based 24 chromosome aneuploidy screening provides more complete and consistent results than FISH. These results also suggest that FISH technology may overestimate the contribution of mitotic error to the origin of aneuploidy at the cleavage stage of human embryogenesis.

[1]  P. Hunt,et al.  To err (meiotically) is human: the genesis of human aneuploidy , 2001, Nature Reviews Genetics.

[2]  H. Danzer,et al.  Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3. , 2005, Fertility and sterility.

[3]  M. Rabinowitz,et al.  Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol , 2010, Human reproduction.

[4]  L. Nilsson,et al.  Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. , 2008, Human reproduction.

[5]  Jacques Cohen,et al.  Increased efficiency of preimplantation genetic diagnosis for infertility using "no result rescue". , 2007, Fertility and sterility.

[6]  H. Weier,et al.  Chromosome abnormalities in human arrested preimplantation embryos: a multiple-probe FISH study. , 1994, American journal of human genetics.

[7]  P. Bossuyt,et al.  In vitro fertilization with preimplantation genetic screening. , 2007, The New England journal of medicine.

[8]  P. Haentjens,et al.  Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. , 2008, Human reproduction.

[9]  N. Treff,et al.  Assessing the reproductive competence of individual embryos: a proposal for the validation of new "-omics" technologies. , 2010, Fertility and sterility.

[10]  Y. Yaron,et al.  Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. , 2008, Fertility and sterility.

[11]  S. Munné,et al.  Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. , 2009, Fertility and sterility.

[12]  Geert Verbeke,et al.  Chromosome instability is common in human cleavage-stage embryos , 2009, Nature Medicine.

[13]  Elpida Fragouli,et al.  Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure. , 2010, Fertility and sterility.

[14]  D. Wells,et al.  Comprehensive molecular cytogenetic analysis of the human blastocyst stage. , 2008, Human reproduction.

[15]  Preimplantation genetic testing: a Practice Committee opinion. , 2007, Fertility and sterility.

[16]  C. Moutou,et al.  ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. , 2009, Human reproduction.

[17]  R. Williamson,et al.  Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization , 2000, Human Genetics.

[18]  Terry Hassold,et al.  The origin of human aneuploidy: where we have been, where we are going. , 2007, Human molecular genetics.

[19]  S. Pickering,et al.  The current status of preimplantation genetic screening: British Fertility Society Policy and Practice Guidelines , 2008, Human fertility.

[20]  Preimplantation genetic testing: a Practice Committee opinion. , 2007, Fertility and sterility.

[21]  L. Gianaroli,et al.  Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. , 2000, Human reproduction.

[22]  Jacques Cohen,et al.  Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. , 2005, Fertility and sterility.

[23]  Michel Camus,et al.  Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. , 2004, Human reproduction.

[24]  N. Muntjewerff,et al.  ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. , 2008, Human reproduction.

[25]  D. Wells,et al.  Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. , 2000, Molecular human reproduction.

[26]  B. Levy,et al.  Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. , 2010, Fertility and sterility.